Studies related to Skeletal Muscle Atrophy and Clenbuterol

Randomized, Double-blind, And Placebo-controlled Trial Of Clenbuterol In Denervated Muscle Atrophy

Effect Decrease
Trial Design Double blind
Trial Length n/a
Number of Subjects 71
Gender n/a
Notes for this study:
Clenbuterol, at 60mcg twice daily, was given to 71 patients suffering brachial plexus injuries (spinal injury).

Clenbuterol, over 3 months of immobility, significantly reduced muscle degradation rates. Decreases were seen in both groups, but were 60-66% greater in placebo.